grepcent public filings, reorganized for comparison

Cadre Holdings, Inc. (CDRE)

CIK: 0001860543. SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies. Latest 10-K as of: 2026-03-10.

SIC breadcrumb: Manufacturing > SIC Major Group 38 > SIC 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1860543. Latest filing source: 0001104659-26-025862.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-03-10 · accession 0001104659-26-025862 · source: SEC companyfacts

Revenue
610,308,000 USD verified
Net income
44,139,000 USD verified
Assets
770,031,000 USD verified
Free cash flow
56,849,000 USD computed
Net margin
7.23% computed
Operating margin
11.04% computed
Revenue YoY
+7.53% computed
ROE
13.89% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

CDRE ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 3842; per-ratio N printed.CDRE ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 3842; per-ratio N printed.RatioCDREPeer medianPercentileNNet margin7.2%7.2%5013Operating margin11.0%11.0%5013Revenue growth7.5%7.4%5414FCF margin9.3%7.7%5414ROE13.9%-1.9%8514ROA5.7%-1.9%6214Liabilities / equity1.420.597714Current ratio3.502.587714

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue610,308,000USD20252026-03-10
Net income44,139,000USD20252026-03-10
Assets770,031,000USD20252026-03-10

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-03-10. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001860543.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2019202020212022202320242025
Revenue404,642,000427,288,000457,837,000482,532,000567,561,000610,308,000
Net income38,453,00012,661,0005,820,00038,641,00036,133,00044,139,000
Operating income49,804,00051,719,00016,716,00056,519,00066,761,00067,351,000
Gross profit152,938,000170,690,000175,678,000200,726,000233,481,000259,628,000
Diluted EPS1.400.440.161.020.901.02
Operating cash flow45,419,00040,094,00046,409,00073,209,00031,777,00063,705,000
Capital expenditures4,708,0002,832,0004,494,0006,727,0005,668,0006,856,000
Dividends paid12,751,00011,509,00012,006,00013,948,00015,448,000
Assets283,279,000311,796,000391,952,000431,179,000652,713,000770,031,000
Liabilities274,428,000223,156,000226,062,000234,017,000341,198,000452,227,000
Stockholders' equity-30,022,0008,851,00088,640,000165,890,000197,162,000311,515,000317,804,000
Cash and cash equivalents124,933,000122,898,000
Free cash flow40,711,00037,262,00041,915,00066,482,00026,109,00056,849,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2019202020212022202320242025
Net margin9.50%2.96%1.27%8.01%6.37%7.23%
Operating margin12.31%12.10%3.65%11.71%11.76%11.04%
Return on equity434.45%14.28%3.51%19.60%11.60%13.89%
Return on assets13.57%4.06%1.48%8.96%5.54%5.73%
Liabilities / equity31.012.521.361.191.101.42
Current ratio1.882.142.502.583.483.50

Industry Peer Context

Each number-line places CDRE against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

CDRE Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 13.CDRE Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 13.13 SIC peersMin -52.7%Median 7.2%Max 28.4%CDRE 7.2%

Operating margin peer context

CDRE Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 13.CDRE Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 13.13 SIC peersMin -50.0%Median 11.0%Max 29.3%CDRE 11.0%

ROE peer context

CDRE ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 14.CDRE ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 14.14 SIC peersMin -136.6%Median -1.9%Max 20.4%CDRE 13.9%

ROA peer context

CDRE ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 14.CDRE ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3842; peer count 14.14 SIC peersMin -94.5%Median -1.9%Max 14.0%CDRE 5.7%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

CDRE FY2025 income statement bridge from reported figures.CDRE FY2025 income statement bridge from reported figures.CDRE income bridgeFY2025: revenue to net incomeSource: SEC companyfacts FY2025.Income statement bridgeReported amount$0.0B$375.0M$750.0M$610.3MRevenue-$350.7MCost$259.6MGross-$192.3MOpEx$67.4MOperating-$23.2MOther/tax$44.1MNet income

Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001104659-26-025862; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001104659-26-025862; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001104659-26-025862; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001104659-26-025862; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

CDRE FY2025 free cash flow bridge from reported figures.CDRE FY2025 free cash flow bridge from reported figures.CDRE free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$63.7MOperating cash flow-$6.9MCapex$56.8MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001104659-26-025862; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001104659-26-025862; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001104659-26-025862; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

CDRE revenue, last 5 periods. Source: SEC companyfacts FY2025.CDRE revenue, last 5 periods. Source: SEC companyfacts FY2025.CDRE RevenueLatest point: FY2025 = $610.3MSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

CDRE net income, last 5 periods. Source: SEC companyfacts FY2025.CDRE net income, last 5 periods. Source: SEC companyfacts FY2025.CDRE Net incomeLatest point: FY2025 = $44.1MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

CDRE operating income, last 5 periods. Source: SEC companyfacts FY2025.CDRE operating income, last 5 periods. Source: SEC companyfacts FY2025.CDRE Operating incomeLatest point: FY2025 = $67.4MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

CDRE gross profit, last 5 periods. Source: SEC companyfacts FY2025.CDRE gross profit, last 5 periods. Source: SEC companyfacts FY2025.CDRE Gross profitLatest point: FY2025 = $259.6MSource: SEC companyfacts FY2025.Fiscal yearGross profit$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

CDRE diluted eps, last 5 periods. Source: SEC companyfacts FY2025.CDRE diluted eps, last 5 periods. Source: SEC companyfacts FY2025.CDRE Diluted EPSLatest point: FY2025 = $1.02/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$0.75/share$1.50/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

CDRE operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.CDRE operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.CDRE Operating cash flowLatest point: FY2025 = $63.7MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

CDRE capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.CDRE capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.CDRE Capital expendituresLatest point: FY2025 = $6.9MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

CDRE dividends paid, last 5 periods. Source: SEC companyfacts FY2025.CDRE dividends paid, last 5 periods. Source: SEC companyfacts FY2025.CDRE Dividends paidLatest point: FY2025 = $15.4MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: PaymentsOfDividends. Source concepts: us-gaap:PaymentsOfDividends.

CDRE assets, last 5 periods. Source: SEC companyfacts FY2025.CDRE assets, last 5 periods. Source: SEC companyfacts FY2025.CDRE AssetsLatest point: FY2025 = $770.0MSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: Assets. Source concepts: us-gaap:Assets.

CDRE liabilities, last 5 periods. Source: SEC companyfacts FY2025.CDRE liabilities, last 5 periods. Source: SEC companyfacts FY2025.CDRE LiabilitiesLatest point: FY2025 = $452.2MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

CDRE stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.CDRE stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.CDRE Stockholders' equityLatest point: FY2025 = $317.8MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

CDRE cash and cash equivalents, last 2 periods. Source: SEC companyfacts FY2025.CDRE cash and cash equivalents, last 2 periods. Source: SEC companyfacts FY2025.CDRE Cash and cash equivalentsLatest point: FY2025 = $122.9MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0M$124.9MFY2024$122.9MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

CDRE free cash flow, last 5 periods. Source: SEC companyfacts FY2025.CDRE free cash flow, last 5 periods. Source: SEC companyfacts FY2025.CDRE Free cash flowLatest point: FY2025 = $56.8MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001104659-26-025862; filed 2026-03-10. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-05. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001860543.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-09-300.13reported discrete quarter
2023-Q12023-03-310.19reported discrete quarter
2023-Q22023-06-300.29reported discrete quarter
2023-Q32023-09-30125,114,00011,053,0000.29reported discrete quarter
2023-Q42023-12-31124,583,0009,594,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-31137,860,0006,928,0000.18reported discrete quarter
2024-Q22024-06-30144,309,00012,567,0000.31reported discrete quarter
2024-Q32024-09-30109,408,0003,655,0000.09reported discrete quarter
2024-Q42024-12-31175,984,00012,983,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-31130,106,0009,248,0000.23reported discrete quarter
2025-Q22025-06-30157,109,00012,211,0000.30reported discrete quarter
2025-Q32025-09-30155,869,00010,941,0000.27reported discrete quarter
2025-Q42025-12-31167,224,00011,739,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-31155,429,0001,975,0000.05reported discrete quarter
2026-Q22026-06-30207,126,00011,407,0000.26reported discrete quarter

Quarterly Charts

CDRE quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.CDRE quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.CDRE Quarterly RevenueLatest point: 2026-Q2 = $207.1MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$125.0M$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001104659-26-091151; filed 2026-08-05. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

CDRE quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.CDRE quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.CDRE Quarterly Net incomeLatest point: 2026-Q2 = $11.4MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001104659-26-091151; filed 2026-08-05. Concept: NetIncomeLossAvailableToCommonStockholdersBasic. Source concepts: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic.

CDRE quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.CDRE quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.CDRE Quarterly Diluted EPSLatest point: 2026-Q2 = $0.26/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$0.25/share$0.50/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001104659-26-091151; filed 2026-08-05. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read CDRE's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read CDRE's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001104659-26-091151.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-05. Report date: 2026-06-30.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the financial condition and results of operations of Cadre Holdings, Inc. (D/B/A The Safariland Group) (“Cadre,” “the Company,” “we,” “us” and “our”) should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of Cadre’s control. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause future results to differ materially from those projected in the forward- looking statements include, but are not limited to, those discussed in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2025 and the section entitled “Cautionary Statement Regarding Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q.

Our Business

We are a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed. We sell a wide range of products including body armor, explosive ordnance disposal equipment, duty gear, remote handling solutions, containers for the storage of radioactive materials, and ventilation and containment solutions through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providing equipment we manufacture as well as third-party products including uniforms, optics, boots, firearms, and ammunition. A substantial portion of our diversified product offering is governed by rigorous safety standards and regulations. Demand for our products is driven by technological advancement as well as recurring modernization and replacement cycles for the equipment to maintain its efficiency, effective performance, and regulatory compliance.

Domestically, we are a top provider of safety holsters and soft body armor for first responders, as well as a top provider of nuclear safety solutions. Globally, we are a leading provider of explosive ordnance disposal technician equipment. We believe we have achieved these positions through our high-quality standards, innovation and a direct connection to the end users. We service the ever-changing needs of our end users by investing in research and development for new product innovation and technical advancements that continually raise the standards for safety equipment in the markets we serve. Our target end user base includes state, local, and international law enforcement, fire and rescue, explosive ordnance disposal technicians, commercial nuclear power plants, emergency medical technicians (“EMT”), fishing and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State (“DoS”), U.S. Department of War (“DoW”), U.S. Department of Interior (“DoI”), U.S. Department of Justice (“DoJ”), U.S. Department of Homeland Security (“DHS”), U.S. Department of Corrections (“DoC”), the Department of Energy (“DoE”), numerous foreign government agencies and other companies involved in the nuclear industry.

In January 2026, the Company acquired TYR Tactical, LLC (“TYR”) for $185.2 million.

In April 2026, the Company acquired Alien Gear holsters and certain assets from Tedder Industries, LLC for $10.3 million.

30

Table of Contents

CADRE HOLDINGS, INC.

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except share and per share amounts)

The following table sets forth a summary of our financial highlights for the periods indicated:

Three Months Ended June 30,Six Months Ended June 30,
(in thousands)2026202520262025
Net sales​ ​ ​$207,126​ ​ ​$157,109​ ​ ​$362,555​ ​ ​$287,215
Net income$11,407$12,211$13,382$21,459
Adjusted EBITDA(1)$41,987$26,994$63,098$47,491
Column 1Column 2
(1)Adjusted EBITDA is a non-GAAP financial measure. See “Non-GAAP Measures” below for our definition of, and additional information about, Adjusted EBITDA, and for a reconciliation to net income, the most directly comparable U.S. GAAP financial measure.

Net sales increased by $50.0 million for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025, primarily as a result of current year acquisitions and increased demand for nuclear safety, armor, and duty gear products.

Net income decreased by $0.8 million for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025, primarily as a result of increased contingent consideration expense, increased compensation expense, and adverse foreign currency fluctuations, partially offset by increased gross profit.

Net sales increased by $75.3 million for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025, primarily as a result of current and prior year acquisitions, partially offset by lower agency demand for hard goods in the Distribution segment.

Net income decreased by $8.1 million for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025, primarily as a result of increased contingent consideration expense, compensation expense, and interest expense, as well as adverse foreign currency fluctuations, partially offset by increased gross profit.

KEY PERFORMANCE METRICS

Orders backlog

We monitor our orders backlog, which we believe is a forward-looking indicator of potential sales. Our orders backlog for products includes all orders that have been received and are believed to be firm. Due to municipal government procurement rules, in certain cases orders included in backlog are subject to budget appropriation or other contract cancellation clauses. Consequently, our orders backlog may differ from actual future sales. Orders backlog can be helpful to investors in evaluating the performance of our business and identifying trends over time.

The following table presents our orders backlog as of the periods indicated:

June 30, 2026December 31, 2025
Orders backlog$367,731$189,799

Orders comprising backlog as of a given balance sheet date are typically invoiced in subsequent periods. The majority of our products are generally processed and shipped within one to three weeks of an order being placed, though the fulfillment time for certain products, for example, explosive ordnance disposal equipment, may take three months or longer. Our orders backlog could experience volatility between periods, including as a result of customer order volumes and the speed of our order fulfillment, which in turn may be impacted by the nature of products ordered, the amount of inventory on hand and the necessary manufacturing lead time.

Orders backlog increased by $177.9 million as of June 30, 2026 compared to December 31, 2025, primarily due to increases of $107.0 million from orders of vehicle blast attenuation seats, blast exposure monitoring sensors, and remotely operated vehicles, $56.1 million from current year acquisitions, $12.6 million from nuclear safety products, and $7.6 million due to international and domestic channels for duty gear holsters, partially offset by a $4.7 million decrease in international and domestic orders for crowd control products.

31

Table of Contents

CADRE HOLDINGS, INC.

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except share and per share amounts)

RESULTS OF OPERATIONS

In order to reflect the way our chief operating decision maker reviews and assesses the performance of the business, Cadre has determined that it has two reportable segments — the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of our business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products. Segment information is consistent with how the chief operating decision maker, our chief executive officer, reviews the business, makes investing and resource allocation decisions and assesses operating performance.

The following table presents data from our results of operations for the three and six months ended June 30, 2026 and 2025 (in thousands unless otherwise noted):

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001104659-26-025862. The complete FY 2025 MD&A is published at /company/CDRE/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2026-03-10. Report date: 2025-12-31.

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the financial condition and results of operations of Cadre Holdings, Inc. (D/B/A The Safariland Group) (“Cadre,” “the Company” “we,” “us” and “our”) should be read together with our audited consolidated financial statements together with related notes thereto, included elsewhere in this Annual Report on Form 10-K. A discussion of changes in our financial condition and the results of operations from the year ended December 31, 2024 to December 31, 2023 can be found in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 11, 2025. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of Cadre’s control. Our actual results may differ significantly from those projected in the forward- looking statements. Factors that might cause future results to differ materially from those projected in the forward- looking statements include, but are not limited to, those discussed in the sections entitled “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” included elsewhere in this Annual Report on Form 10-K. Certain total amounts may not foot due to rounding.

Overview and 2025 Financial Highlights

Cadre is a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed. We sell a wide range of products including body armor, explosive ordnance disposal equipment, duty gear, remote handling solutions, containers for the storage of radioactive materials, and ventilation and containment solutions through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providing equipment we manufacture as well as third-party products including uniforms, optics, boots, firearms and ammunition. The majority of our diversified product offering is governed by rigorous safety standards and regulations. Demand for our products is driven by technological advancement as well as recurring modernization and replacement cycles for the equipment to maintain its efficiency, effective performance and regulatory compliance.

We service the ever-changing needs of our end users by investing in research and development for new product innovation and technical advancements that continually raise the standards for safety equipment. Our target end user base includes domestic and international first responders such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing and wildlife enforcement and departments of corrections, as well as federal agencies including DoS, DoW, DoI, DoJ, DHS, DoC, DoE and numerous foreign government agencies in over 100 countries.

In April 2025, the Company acquired Zircaloy for $98.9 million.

In January 2026, the Company acquired TYR Tactical, LLC for $174.0 million.

The following table sets forth a summary of our financial highlights for the periods indicated:

Year Ended December 31,
(in thousands)20252024
Net sales​ ​ ​$610,308​ ​ ​$567,561
Net income$44,139$36,133
Adjusted EBITDA(1)$111,708$104,840
Column 1Column 2
(1)Adjusted EBITDA is a non-GAAP financial measure. See “Non-GAAP Measures” below for our definition of, and additional information about, Adjusted EBITDA, and for a reconciliation to net income, the most directly comparable U.S. GAAP financial measure.

37

Table of Contents

Net sales increased by $42.7 million for the year ended December 31, 2025 as compared to December 31, 2024, primarily as a result of the recent acquisitions and higher demand for duty gear products, partially offset by a decline in EOD products and existing nuclear safety products.

Net income increased by $8.0 million for the year ended December 31, 2025 as compared to the year ended December 31, 2024, primarily as a result of higher gross profit partially offset by an increase in selling, general and administrative expenses from acquisitions, acquisition related costs, higher interest expense, and higher stock compensation expense.

KEY PERFORMANCE METRICS

Orders backlog

We monitor our orders backlog, which we believe is a forward-looking indicator of potential sales. Our orders backlog for products includes all orders that have been received and are believed to be firm. Due to municipal government procurement rules, in certain cases orders included in backlog are subject to budget appropriation or other contract cancellation clauses. Consequently, our orders backlog may differ from actual future sales. Orders backlog can be helpful to investors in evaluating the performance of our business and identifying trends over time.

The following table presents our orders backlog as of the periods indicated:

December 31, 2025December 31, 2024
Orders backlog$189,799$128,814

Orders comprising backlog as of a given balance sheet date are typically invoiced in subsequent periods. A substantial portion of our products are processed and shipped within 60 days of an order being placed, though the fulfillment time for certain products, for example, explosive ordnance disposal equipment, may take three months or longer. Our orders backlog could experience volatility between periods, including as a result of customer order volumes and the speed of our order fulfillment, which in turn may be impacted by the nature of products ordered, the amount of inventory on hand and the necessary manufacturing lead time.

Orders backlog increased by $61.0 million as of December 31, 2025 compared to December 31, 2024, primarily due to increases of $51.3 million from the Zircaloy acquisition, $12.5 million from global EOD, $3.7 million from chemiluminescent products and $1.6 million from U.S. government and international channels for duty gear holsters, partially offset by reductions of $7.7 million from existing nuclear safety products.

DESCRIPTION OF CERTAIN COMPONENTS OF FINANCIAL DATA

Net sales

We recognize revenue when a contract exists with a customer that specifies the goods and services to be provided at an agreed upon sales price and when the performance obligation is satisfied by transferring the goods or service to the customer. The performance obligation is considered satisfied when control transfers, which is generally determined when products are shipped or delivered to the customer but could be delayed until the receipt of customer acceptance, depending on the terms of the contract. The Company also has certain long-term contracts that contain performance obligations that are satisfied over time. The Company invoices the customer once the billing milestone is reached and collects under customary short-term credit terms. For long-term contracts, the Company recognizes revenue using the input method based on costs incurred, as this method is an appropriate measure of progress toward the complete satisfaction of the performance obligation.

At the time of revenue recognition, we also provide for estimated sales returns and miscellaneous claims from customers as reductions to revenues. Charges for shipping and handling fees billed to customers are included in net sales. Taxes collected from customers and remitted to government authorities are reported on a net basis and are excluded from sales. See Note 1 “Significant Accounting Policies — Revenue Recognition” to our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.

38

Table of Contents

We generate sales primarily through our four main sales channels: U.S. state and local agencies, international, U.S. federal agencies, and commercial.

Costs and Expenses

Cost of goods sold. Cost of goods sold includes raw material purchases, manufacturing-related labor costs, contracted labor, project costs, shipping costs, allocated manufacturing overhead, facility costs, depreciation and amortization, and product warranty costs.

Selling, general and administrative. Selling, general and administrative (“SG&A”) expense includes personnel-related costs, professional services, marketing and advertising expense, research and development, depreciation and amortization, and impairment charges.

Restructuring and transaction costs. Restructuring costs consist primarily of termination benefits and relocation of employees, termination of operating leases and other contracts related to consolidating or closing facilities. Transaction costs consist of legal fees and consulting costs related to one-time transactions.

Related party expense. Related party expense primarily consists of one-time fees paid to related parties for transaction related services.

Interest expense. Interest expense consists primarily of interest on outstanding debt.

Other income (expense), net. Other income (expense), net primarily consists of gains and losses from foreign currency transactions.

Provision for income taxes. A provision or benefit for income tax is calculated for each of the jurisdictions in which we operate. The provision or benefit for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The benefit or provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the book and tax bases of assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. See Note 16 “Income Taxes” in our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.

RESULTS OF OPERATIONS

In order to reflect the way our chief operating decision maker reviews and assesses the performance of the business, Cadre has determined that it has two reportable segments — the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of our business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products. Segment information is consistent with how the chief operating decision maker, our chief executive officer, reviews the business, makes investing and resource allocation decisions and assesses operating performance.

39

Table of Conten

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for CDRE

Indicators mapped to this company's SIC classification (industry 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Inflation (CPI / PCE / PPI), US labor market, Growth & output, Money & trade, Government finances, Sector employment, Industrial orders & inventories, Trade & external.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/CDRE.md · JSON record: /company/CDRE.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt